The Kallikrein-Kinin system

Acta Physiologica

Volumn 206, Issue 4, 2012, Pages 215-219

  Hillmeister, P ^a   Persson, P B ^b  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; ARACHIDONIC ACID; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTRINSIC FACTOR; KALLIKREIN; KININ; KININOGEN; PROSTAGLANDIN; SERINE PROTEINASE; VASODILATOR AGENT;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; COMPLEMENT ACTIVATION; HEMOSTASIS; HUMAN; HYPERTENSION; INNATE IMMUNITY; KALLIKREIN KININ SYSTEM; KIDNEY FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINALYSIS; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; HUMANS; IMMUNITY, INNATE; KALLIKREIN-KININ SYSTEM; KIDNEY; KININOGENS; KININS;

EID: 84868151865     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12007     Document Type: Article

References (53)

1. Abelous, J.E. & Bardier, E. 1909. Les substances hypotensives de l'urine humaine normale. Compt Rend Soc Biol 66, 511-512.
2. Aljabri, M.B., Songstad, N.T., Lund, T., Serrano, M.C., Andreasen, T.V., Al-Saad, S., Lindal, S., Sitras, V., Acharya, G. & Ytrehus, K. 2011. Pregnancy protects against antiangiogenic and fibrogenic effects of angiotensin II in rat hearts. Acta Physiol (Oxf) 201, 445-456.
3. Armstrong, J.A. 2007. Urinalysis in Western culture: a brief history. Kidney Int 71, 384-387.
4. Bader, M. 2009. Kallikrein-kinin system in neovascularization. Arterioscler Thromb Vasc Biol 29, 617-619.
5. Bagher, P. & Segal, S.S. 2011. Regulation of blood flow in the microcirculation: role of conducted vasodilation. Acta Physiol (Oxf) 202, 271-284.
6. Blankesteijn, W.M., Creemers, E., Lutgens, E., Cleutjens, J.P., Daemen, M.J. & Smits, J.F. 2001. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 173, 75-82.
7. Carretero, O.A. & Scicli, A.G. 1980. The renal kallikrein-kinin system. Am J Physiol 238, F247-255.
8. Dahl, T.D., Hultstrom, M., Iversen, B.M. & Helle, F. 2011. Adenosine sensitization after angiotensin II stimulation in afferent arterioles from normal rats does not occur during two-kidney, one-clip hypertension. Acta Physiol (Oxf) 201, 289-294.
9. Duchene, J. & Ahluwalia, A. 2009. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease. Curr Opin Pharmacol 9, 125-131.
10. Duchene, J., Cayla, C., Vessillier, S., Scotland, R., Yamashiro, K., Lecomte, F., Syed, I., Vo, P., Marrelli, A., Pitzalis, C. et al. 2009. Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis. Arterioscler Thromb Vasc Biol 29, 1757-1763.
11. Duelsner, A., Gatzke, N., Glaser, J., Hillmeister, P., Li, M., Lee, E.J., Lehmann, K., Urban, D., Meyborg, H., Stawowy, P., Busjahn, A., Nagorka, S., Persson, A.B. & Buschmann, I.R. 2012. Granulocyte colony-stimulating factor improves cerebrovascular reserve capacity by enhancing collateral growth in the circle of Willis. Cerebrovasc Dis 33, 419-429.
12. Edvinsson, L. & Povlsen, G.K. 2011. Late cerebral ischaemia after subarachnoid haemorrhage: is cerebrovascular receptor upregulation the mechanism behind? Acta Physiol (Oxf) 203, 209-224.
13. Emanueli, C., Bonaria Salis, M., Stacca, T., Pintus, G., Kirchmair, R., Isner, J.M., Pinna, A., Gaspa, L., Regoli, D., Cayla, C., Pesquero, J.B., Bader, M. & Madeddu, P. 2002. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation 105, 360-366.
14. Fandriks, L. 2011. The renin-angiotensin system and the gastrointestinal mucosa. Acta Physiol (Oxf) 201, 157-167.
15. Frey, E. 1926. Zusammenhange zwischen Herzarbeit und Nierentatigkeit. Arch Klin Chir 142, 663.
16. Gill, J.R. Jr, Melmon, K.L., Gillespie, L. Jr & Bartter, F.C. 1965. Bradykinin and renal function in normal man: effects of adrenergic blockade. Am J Physiol 209, 844-848.
17. Hillmeister, P., Gatzke, N., Dulsner, A., Bader, M., Schadock, I., Hoefer, I., Hamann, I., Infante-Duarte, C., Jung, G., Troidl, K. et al. 2011. Arteriogenesis is modulated by bradykinin receptor signaling. Circ Res 109, 524-533.
18. Hirsch, E.F., Nakajima, T., Oshima, G., Erdos, E.G. & Herman, C.M. 1974. Kinin system responses in sepsis after trauma in man. J Surg Res 17, 147-153.
19. Holzer, P. 2011. Acid sensing by visceral afferent neurones. Acta Physiol (Oxf) 201, 63-75.
20. Kanlop, N., Thommasorn, S., Palee, S., Weerateerangkul, P., Suwansirikul, S., Chattipakorn, S. & Chattipakorn, N. 2011. Granulocyte colony-stimulating factor stabilizes cardiac electrophysiology and decreases infarct size during cardiac ischaemic/reperfusion in swine. Acta Physiol (Oxf) 202, 11-20.
21. Kaplan, A.P. & Ghebrehiwet, B. 2010. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 47, 2161-2169.
22. Krankel, N. & Madeddu, P. 2009. Helping the circulatory system heal itself: manipulating kinin signaling to promote neovascularization. Expert Rev Cardiovasc Ther 7, 215-219.
23. Kraut, H.F.E. & Werle, E. 1930. Der Nachweis eines Kreislaufisormons in der Pankreasdruse. Hoppe-Seyler's Z Physiol Chem 189, 97-106.
24. Leeb-Lundberg, L.M., Marceau, F., Muller-Esterl, W., Pettibone, D.J. & Zuraw, B.L. 2005. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57, 27-77.
25. Lominadze, D., Dean, W.L., Tyagi, S.C. & Roberts, A.M. 2010. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf) 198, 1-13.
26. Marceau, F. & Regoli, D. 2004. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3, 845-852.
27. Marketou, M.E. & Vardas, P.E. 2012. Bradykinin in the treatment of arterial hypertension: friend or foe? Hellenic J Cardiol 53, 91-94.
28. McGiff, J.C., Terragno, N.A., Malik, K.U. & Lonigro, A.J. 1972. Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31, 36-43.
29. Merino, V.F., Todiras, M., Mori, M.A., Sales, V.M., Fonseca, R.G., Saul, V., Tenner, K., Bader, M. & Pesquero, J.B. 2009. Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J Mol Med (Berl) 87, 953-963.
30. Morabito, C., Bosco, G., Pilla, R., Corona, C., Mancinelli, R., Yang, Z., Camporesi, E.M., Fano, G. & Mariggio, M.A. 2011. Effect of pre-breathing oxygen at different depth on oxidative status and calcium concentration in lymphocytes of scuba divers. Acta Physiol (Oxf) 202, 69-78.
31. Moreau, M.E., Garbacki, N., Molinaro, G., Brown, N.J., Marceau, F. & Adam, A. 2005. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99, 6-38.
32. Nasjletti, A. & Malik, K.U. 1981. Renal kinin-prostaglandin relationship: implications for renal function. Kidney Int 19, 860-868.
33. Persson, A.B. & Buschmann, I.R. 2011. Vascular growth in health and disease. Front Mol Neurosci 4, 14.
34. Pesquero, J.B. & Bader, M. 2006. Genetically altered animal models in the kallikrein-kinin system. Biol Chem 387, 119-126.
35. Pisano, J.J., Corthorn, J., Yates, K. & Pierce, J.V. 1978. The kallikrein-kinin system in the kidney. Contrib Nephrol 12, 116-125.
36. Pribram, H. & Herrnheiser, S. 1920. The Nondialyable Constituents of Human Urine. Biochem Z 111, 30-80.
37. Raja, S.N., Campbell, J.N., Meyer, R.A. & Colman, R.W. 1992. Role of kinins in pain and hyperalgesia: psychophysical studies in a patient with kininogen deficiency. Clin Sci (Lond) 83, 337-341.
38. Regoli, D., Plante, G.E. & Gobeil, F. Jr 2012. Impact of kinins in the treatment of cardiovascular diseases. Pharmacol Ther 135, 94-111.
39. Sainz, I.M., Pixley, R.A. & Colman, R.W. 2007. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb Haemost 98, 77-83.
40. Santos, R.L., Marin, E.B., Goncalves, W.L., Bissoli, N.S., Abreu, G.R. & Moyses, M.R. 2010. Sex differences in the coronary vasodilation induced by 17 beta-oestradiol in the isolated perfused heart from spontaneously hypertensive rats. Acta Physiol (Oxf) 200, 203-210.
41. Schachter, M. 1979. Kallikreins (kininogenases)-a group of serine proteases with bioregulatory actions. Pharmacol Rev 31, 1-17.
42. Schreiber, A.D., Zweiman, B., Atkins, P., Goldwein, F., Pietra, G., Atkinson, B. & Abdou, N.I. 1976. Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood 48, 567-580.
43. Schulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M.A. et al. 2009. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat Med 15, 788-793.
44. Scicli, A.G., Gandolfi, R. & Carretero, O.A. 1978. Site of formation of kinins in the dog nephron. Am J Physiol 234, F36-40.
45. Silvestre, J.S., Bergaya, S., Tamarat, R., Duriez, M., Boulanger, C.M. & Levy, B.I. 2001. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res 89, 678-683.
46. Stein, J.H., Congbalay, R.C., Karsh, D.L., Osgood, R.W. & Ferris, T.F. 1972. The effect of bradykinin on proximal tubular sodium reabsorption in the dog: evidence for functional nephron heterogeneity. J Clin Invest 51, 1709-1721.
47. Styp-Rekowska, B., Hlushchuk, R., Pries, A.R. & Djonov, V. 2011. Intussusceptive angiogenesis: pillars against the blood flow. Acta Physiol (Oxf) 202, 213-223.
48. Terragno, N.A., Lonigro, A.J., Malik, K.U. & McGiff, J.C. 1972. The relationship of the renal vasodilator action of bradykinin to the release of a prostaglandin E-like substance. Experientia 28, 437-439.
49. Vlasova, M., Purhonen, A.K., Jarvelin, M.R., Rodilla, E., Pascual, J. & Herzig, K.H. 2010. Role of adipokines in obesity-associated hypertension. Acta Physiol (Oxf) 200, 107-127.
50. Wang, Y., Yang, J.N., Arner, A., Boels, P.J. & Fredholm, B.B. 2010. Adenosine A(1) receptors and vascular reactivity. Acta Physiol (Oxf) 199, 211-220.
51. Ward, P.E., Erdos, E.G., Gedney, C.D., Dowben, R.M. & Reynolds, R.C. 1976. Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins. Biochem J 157, 643-650.
52. Webster, M.E. & Gilmore, J.P. 1964. Influence of Kallidin-L0 on Renal Function. Am J Physiol 206, 714-718.
53. Wong, P.Y., Williams, G.H. & Colman, R.W. 1983. Studies on the renin-angiotensin system in a kininogen-deficient individual. Clin Sci (Lond) 65, 121-126.